Sethuraman Natarajan (CIK 1873394) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy TRDA (55,800 shares), Sell TRDA (3,898 shares), Sell TRDA (7,577 shares), Sell TRDA (1,760 shares), Buy TRDA (60,800 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Buy | 55,800 | $0 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 3,898 | $45,451 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 7,577 | $89,106 |
| 2025-09-04 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 1,760 | $9,557 |
| 2025-03-04 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Buy | 60,800 | $0 |
| 2025-03-04 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 6,138 | $71,692 |
Source: SEC Form 4 filings · as of 2026-03-03